Asmaa A E ALİ, Mohamed E. ABDELRAHİM, Neveen A ELMOSLAMY, Amira S. A. SAİD, Mohamed H. MEABED

Comparison between Nitazoxanide and Metronidazole in the Treatment of Protozoal Diarrhea in Children

Diarrheal disease is a leading cause of illness and death in children worldwide. Diarrhea is caused by a blend of bacterial, viral and parasitic pathogens. Enteric protozoal infections such as giardiasis, amebiasis and cryptosporidiosis are among the most common and most prevalent forms of gastrointestinal parasitic infections worldwide. Both nitazoxanide and metronidazole are used in treatment of protozoal diarrhea. Nitazoxanide was found to have a very broad spectrum of activity against many forms of parasites. Metronidazole also produces good results when it is used for treatment of parasitic infections. The aim in this study was to evaluate and compare the effect of nitazoxanide and metronidazole in treatment of protozoal diarrhea in children. This study was carried out on 160 diarrheic patients (83 males and 77 females), aged from 1-11 years old collected from the-clinics of pediatric department at Beni suef University Hospital. Patients were divided into two groups. Group A received Nitazoxanide 100 mg in 1-4 years aged patients and 200 mg in 4-11 years aged patients twice daily for 3 days respectively, Group B received Metronidazole 50 mg/Kg/body weight daily for 7 days. Patients were represented to full history taking, physical examination, laboratory investigations in the form of stool analysis, culture and complete blood count (CBC). There was a significant increase in the number of cases resolved by Nitazoxanide compared to Metronidazole group in both amebiasis and giardiasis (p-value < 0.05) with similar clinical improvement when using Nitazoxanide for 3 days and Metronidazole for 7 days. This study confirms the efficacy and safety of nitazoxanide as a 3-day treatment of diarrhea due to giardiasis & amebiasis in children. A 3-day course of nitazoxanide could replace much longer regimens of metronidazole

PDF

___

1. Niehaus MD, Moore SR, Patrick PD, Derr LL, Lorntz B, Lima AA, Guerrant RL. Early childhood diarrhea is associated with diminished cognitive function 4 to 7 years later in children in a northeast Brazilian shantytown. Am J Trop Med Hyg. 2002; 66(5):590-593.

2. Farthing M J. Diarrhea: a significant worldwide problem. Int j antimicrob Agents. 2000;14(1):65-9.

3. Roy CC, Silverman A, Alagille D. Diarrheal Disorders. Pediatric Clinical Gastroenterology. 4th ed. Mosby-year book. St. Louis. 1995;216-34.

4. Bhan MK, Bhandari N, Bhatnagar S, Bahi R. epidemiology and management of persistent diarrhea in children of developing countries. Indian J Med Res. 1996; 18:103-114.

5. Schiller LR. Diarrheal disease. Med Clinic North Am. 2000; 84(5):1259-74.

6. Ono K, Rai SK, Chikahira M, Fujimoto T, Shibata H, Wada Y, Tsuji H, Oda Y, Rai G, Shrestha CD, Masuda K, Shrestha HG, Matsumura T, Hotta H, Kawamura T, Uga S. Seasonal distribution of enteropathogens detected from diarrheal stool and water samples collected in Kathmandu, Nepal. Southeast Asian J Trop Med public Health. 2001;32(3):520-526.

7. Checkley W, Epstein LD, Gilman RH, Cabrera L, Black RE. Effects of acute diarrhea on linear growth in Peruvian children. Am J Epidermiol. 2003; 157(2):166-175.

8. Ochoa TJ, White AC Jr. Nitazoxanide for the treatment of intestinal parasite in children. Pediatr Infect Dis J. 2005; 24(7): 641-42.

9. Abdel-Rahman MS, El-Bahy MM, El-Bahy NM. Testing the parasiticidal efficacy of nitazoxanide. Alex J Vet Sci. 1997; 13:447–58.

10. Micromedex T. Drug Information for the Health Care Professional. Greenwood Village CO. 2006;1:2069.

11. Bowman WC, Rand MJ. Treatment of Trichomonas urogenitalis. Textbook of Pharmacology. 2nd ed. Blackwell Scientific Publications. 1980;36:16.

12. Kosek M, Bern C, Guerrant RL. The global burden of diarrheal disease as estimated from studies published between 1992 and 2000. Bull World Health Organ. 2003; 81(3):197-204.

13. Mathan VI. Diarrheal diseases. Br Med Bull. 1998;54 (2):407-419.

14. Land KM, Johnson PJ. Molecular basis of metronidazole resistance in pathogenic bacteria and protozoa. Drug Resist Updat. 1999; 2:289–94.

15. Diniz CG, Santos SG, Pestana AC, Farias LM, Carvalho MA, Auxiliadora M. Chromosomal breakage in the B. fragilis group induced by metronidazole treatment. Anaerobe. 2000;6(3):149–53.

16. Speich B, Marti H, Ame SM, Ali SM, Bogoch II, Utzinger J, Albonico M , Keiser J. Prevalence of intestinal protozoa infection among school-aged children on Pemba Island, Tanzania and effect of single-dose albendazole, nitazoxanide and albendazolenitazoxanide. Parasit Vectors. 2013;6:3.

17. Escobedo AA, Alvarez G, GonzaLez ME, Almirall P, Can˜ete R, Cimerman S, Ruiz A, Perez R. The treatment of giardiasis in children: single-dose tinidazole compared with 3 days of nitazoxanide. Ann Trop Med Parasitol. 2008;102(3):199–207.

18. Rossignol JF, Kabil SM, El-Gohary Y, Younis AM. Nitazoxanide in the treatment of amoebiasis. Trans R Soc Trop Med Hyg. 2007;101(10):1025-31.

19. Davila-Gutterrez CE, Vasquez C, Trujillo-Hernandez B, Huerta M. Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children. Am J Trop Med Hyg. 2002;66(3):251–4.

20. Aladwan M, Abu-Rumman MA, Jarrar YB, Khreisat E, Khreisat AF, Alshiab SM, Alsmadi N, Al-Ali FBMS A, Aburumman FM, Al Abdallat G, Naemat F. Relationship between metronidazole and co-trimoxazole on eradication of entamoeba histolytica. Am J Microbiol. 2012;3(2):31-3.

21. Talari SA, Momtazmanesh N, Talebian A, Khorshidi A, Taghavi A, Fakharian E, Talari MR, Mokhtari Z. Comparison of Metronidazole and Furazolidone Against Giardia lamblia in Children. J Med Sci. 2006;6(3):378-81.

22. Alizadeh A, Ranjbar M, Kashani KM, Taheri MM, Bodaghi M. Albendazole versus metronidazole in the treatment of patients with giardiasis in the Islamic Republic of Iran. East Mediterr Health J. 2006;12(5):548-54.

23. Yereli K, Balcioglu IC, Ertan P, Limoncu E, Onağ A. Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey. Clin Microbiol Infect. 2004;10(6):527-9.

24. Ozbilgin A, Ertan P, Yereli K, Tamay AT, Kurt O, Degerli K, Balcioglu IC, Ok UZ, Onag A. Giardiasis treatment in Turkish children with a single dose of ornidazole. Scand J Infect Dis. 2002;34(12):918-20.

25. Sadjjadi SM, Alborzi AW, Mostovfi H. Comparative clinical trial of mebendazole and metronidazole in giardiasis of children. J Trop Pediatr. 2001;47(3):176-8.

26. Ortiz JJ, Ayoub A, Gargala G, Chegne NL, Favennec L . Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru. Aliment Pharmacol Ther. 2001;15(9):1409-15.

27. Pehrson PO, Bengtsson E. A Long-term Follow up Study of Amoebiasis Treated with Metronidazole. Scand J Infect Dis. 1984;16( 2):195-8.

28. Raether W, Ha¨nel H. Nitro heterocyclic drugs with broad spectrum activity. Parasitol Res. 2003;90(1):19–39.

29. Dieterich DT, Lew EA, Kotler DP, Poles MA, Orenstein JM. Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. J Infect Dis.1994;169(1):178–83.

30. Stockis A, Deroubaix X, Lins R, Jeanbaptiste B, Calderon P, Rossignol JF. Pharmacokinetics of nitazoxanide after single oral dose administration in 6 healthy volunteers. Int J Clin Pharmacol Ther. 1996;34(8):349–51.

31. Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: A prospective randomized double blind a placebo controlled study of nitazoxanide. J Infect Dis.2001;184(1):103-6.

32. Adagu IS, Nolder D, Warhurst DC, Rossignol JF. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J Antimicrob Chemother. 2002;49(1):103–11.